Trial Profile
A mechanistic study to evaluate the effect of Serelaxin on left ventricular function and its correlation with outcome in acute heart failure
Status:
Recruiting
Phase of Trial:
Phase III
Latest Information Update: 26 Mar 2015
Price :
$35
*
At a glance
- Drugs Serelaxin (Primary)
- Indications Acute heart failure
- Focus Therapeutic Use
- 26 Mar 2015 New trial record